Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina

Mycoses

Volumn 52, Issue 1, 2009, Pages 53-59

  Luque, A G ^a,b   Biasoli, M S ^b   Tosello, M E ^b   Binolfi, A ^b   Lupo, S ^c   Magaro H M ^b  

^a CEREMIC   (Argentina)

^b CEREMIC   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Antifungal susceptibility; Candida; HIV; Oral carriage

Indexed keywords

ABACAVIR; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; NELFINAVIR; NYSTATIN;

ADOLESCENT; ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARGENTINA; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; FUNGAL MORPHOLOGY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; MYCOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; YEAST;

ADULT; ANTIFUNGAL AGENTS; ARGENTINA; CANDIDA; CARRIER STATE; DRUG RESISTANCE, FUNGAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOUTH;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; HELIANTHUS;

EID: 57649231150     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01542.x     Document Type: Article

References (41)

1. Urizzar JMA. Candidiasis orales. Rev Iberoam Micol 2002 19 : 17 21.
2. Chave JP, Durussel C, Glauser MP, Bille J. Asymtomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile. Clin Microbiol Infect 1996 18 : 249 52.
3. Davies AN, Brailsford S, Broadley K, Beighton D. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 2002 17 : 79 84.
4. Gugnami HC, Becker K, Fegeler W et al. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 2003 46 : 299 306.
5. Jabra-Rizk MA, Falkler WA, Enwonwu CO, Onwujekwe DI, Merz WG, Meiller TF. Prevalence of yeast among children in Nigeria and the United States. Oral Microbiol Immunol 2001 16 : 383 5.
6. Gutiérrez J, Morales P, Gonzáles MA, Quindós G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002 42 : 207 27.
7. Kirkpatrick WR, Revankar SG, McAtee RK et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clín Microbiol 1998 36 : 3007 12.
8. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiology 1995 141 : 1507 21.
9. Laet Sant'Ana P, Milan EP, Martinez R et al. Multicenter brazilian study of oral Candida species isolated from AIDS patients. Mem Inst Oswaldo Cruz 2002 97 : 253 7.
10. Rodrigues Costa C, Aquino Lemos J, Sena Passos X et al. Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia 2006 162 : 45 50.
11. Saag MS, Fessel WJ, Kaufman CA et al. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients. AIDS Res Hum Retroviruses 1999 15 : 1413 17.
12. Redding SW, Zellars RC, Kirkpatrick WR et al. Epidemiology of oropharyngeal Candida colonization and infection in patient receiving radiation for head and neck cancer. J Clin Microbiol 1999 37 : 3896 900.
13. Sobel JD, Ohmit SE, Schuman P et al. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2001 183 : 286 93.
14. Garcia Heredia M, Garcia SD, Copolillo EF et al. Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents. Rev Argent Microbiol 2006 38 : 9 12.
15. Rodero L, Davel G, Soria M et al. Multicenter study of fungemia due to yeasts in Argentina. Rev Argent Microbiol 2005 37 : 189 95.
16. Buscemi L, Arechavala A, Negroni R. Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muniz Infectious Diseases Hospital. Rev Iberoam Micol 2004 21 : 177 81.
17. Mujica MT, Finquelievich JL, Jewtuchowicz V, Iovannitti CA. Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001. Rev Argent Microbiol 2004 36 : 107 12.
18. Giusiano GE, Mangiaterra M, Rojas F, Gomez V. Yeasts species distribution in neonatal intensive care units in northeast Argentina. Mycoses 2004 47 : 300 3.
19. Cuenca-Estrella M, Rodero L, Garcia-Effron G, Rodriguez-Tudela JL. Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999. J Antimicrob Chemother 2002 49 : 981 7.
20. Saporiti AM, Gomez D, Levalle S et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev Argent Microbiol 2001 33 : 217 22.
21. Rodero L, Davel G, Cordoba S, Soria M, Canteros C, Hochenfellner F. Multicenter study on nosocomial candidiasis in the Republic of Argentina. Rev Argent Microbiol 1999 31 : 114 19.
22. Rodero L, Boutureira M, Demkura H et al. Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults. Rev Argent Microbiol 1997 29 : 7 15.
23. Negroni M, Gonzalez MI, Levin B, Cuesta A, Iovannitti C. Candida carriage in the oral mucosa of a student population: adhesiveness of the strains and predisposing factors. Rev Argent Microbiol 2002 34 : 22 28.
24. Al Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on pal's agar. J Clin Microbiol 2003 41 : 4787 9.
25. Donnelly S, Sullivan DJ, Shanley D, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999 145 : 1871 82.
26. Binolfi A, Biasoli MS, Luque AG, Tosello ME, Magaró HM. High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol 2005 43 : 431 7.
27. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, 2nd edn. Document M 27 A2. Villonava, PA : NCCLS, 2002 : 1987 98.
28. Felix DH, Wray D. The prevalence of oral candidiasis in HIV-infected individuals and dental attenders in Edinburg. J Oral Pathol Med 1993 22 : 418 20.
29. Schoofs AS, Odds FC, Colebunders R, Ieven M, Goossens H. Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses 1998 41 : 203 11.
30. Sullivan DJ, Moran G, Donnelly S et al. Candida dubliniensis: an update. Rev Iberoam Micol 1999 16 : 72 76.
31. Basu S, Gugnani HC, Joshi S, Gupta N. Distribution of Candida species in different clinical sources in Delhi, India, and proteinase and phospholipase activity of Candida albicans isolates. Rev Iberoam Micol 2003 20 : 137 40.
32. Giammanco GM, Pizzo G, Pecorella S et al. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects. Oral Microbiol Immunol 2002 17 : 89 94.
33. Meiller TF, Jabra-Rizk MA, Baqui A et al. Oral Candida dubliniensis as clinically important species in HIV-seropositive patients in United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 1999 88 : 573 80.
34. Pipolo Milán E, de Laet Sant'Ana P, Salles de Azevedo Melo A et al. Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diagn Microbiol Infect Dis 2001 41 : 29 35.
35. Campisi G, Pizzo G, Milici ME, Mancuso S, Margiotta V. Candidal carriage in the oral cavity of human immunodeficiency virus infected subjets. Oral Surg Med Oral Pathol Oral Radiol Endod 2002 93 : 281 6.
36. Carrillo Muñoz AJ, Tur C, Estivill D et al. Resistencia in vitro al fluconazol e itraconazol en aislamientos clínicos de Candida spp y Cryptoccocus neoformans. Rev Iberoam Micol 1997 14 : 50 54.
37. Giammanco GM, Pecorella S, Distefano S, Pecoraro V, Milici ME, Pizzo G. Fluconazole susceptibility of italian Candida dubliniensis clinical isolates determined by reference and simplified tests. Microbiologica 2001 24 : 397 404.
38. Quindós G, Carrillo Muñoz AJ, Arévalo MP et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000 46 : 395 401.
39. Dick JD, Merz WG, Saral R. Incidence of polyene-resistant yeast recovered from clinical specimens. Antimicrob Agents Chemother 1980 18 : 158 63.
40. Powderly WG, Kobayashi GS, Herzig GP. Amphotericin B resistant yeast infection in severely immunocompromised patients. Am J Med 1988 84 : 826 32.
41. Pfaller MA, Diekema DJ, Jones RN et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001 39 : 3254 9.